3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Neoplasm Metastasis
7
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Tongue Neoplasms
1
Thymoma
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Laryngeal Neoplasms
1
Hypoxia
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Gliosarcoma
1
Interventions
Gemcitabine
5
Paclitaxel
4
Nivolumab
3
cobimetinib
2
atezolizumab
2
adavosertib
2
Ramucirumab
2
N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide
2
Carboplatin
2
zansecimab
1
tocilizumab
1
tivozanib
1
tislelizumab
1
temsirolimus
1
ridaforolimus
1
plocabulin
1
pexidartinib
1
pevonedistat
1
pembrolizumab
1
pamiparib
1
obinutuzumab
1
necitumumab
1
liposomal doxorubicin
1
lenvatinib
1
glasdegib
1
futuximab
1
demplatin pegraglumer
1
birinapant
1
avelumab
1
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumors
×
NVP-BKM120
×
Clear all
No trials found.